share_log

TD Cowen Initiates UpStream Bio(UPB.US) With Buy Rating

Futu News ·  Nov 5 21:31  · Ratings

TD Cowen analyst Yaron Werber initiates coverage on $UpStream Bio (UPB.US)$ with a buy rating.

According to TipRanks data, the analyst has a success rate of 57.9% and a total average return of 14.1% over the past year.

AnalystRecentRatingAutoNews_85907936099785_20241105_6a3c31a07a4dbb5ccd0ca09eb0e9a281c7a7611c_1730813450472120_nn_en

Furthermore, according to the comprehensive report, the opinions of $UpStream Bio (UPB.US)$'s main analysts recently are as follows:

  • Upstream Bio's primary asset, verekitug, is a recombinant human IgG1 monoclonal antibody designed to target the thymic stromal lymphopoietin receptor, which is intended for the treatment of severe asthma, chronic rhinosinusinitis with nasal polyps, and COPD. Analysts view verekitug as the central catalyst for the company's stock performance over the medium to long term as its clinical profile continues to develop.

  • The initiation of coverage on Upstream Bio highlighted the company's verekitug as a 'differentiated fast follower' that potentially offers greater potency and more extended dosing intervals in comparison to Tezspire. The Phase 1 data revealed 'rapid, deep, and sustained effects' on asthma biomarkers.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment